Rima Nabbout Selected Research

Myoclonic Epilepsies (Myoclonic Encephalopathy)

1/2022	International consensus on diagnosis and management of Dravet syndrome.
1/2022	Development and Validation of a Prediction Model for Early Diagnosis of SCN1A-Related Epilepsies.
10/2021	Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial.
1/2021	Treatment with fenfluramine in patients with Dravet syndrome has no long-term effects on weight and growth.
1/2021	A survey of the European Reference Network EpiCARE on clinical practice for selected rare epilepsies.
1/2021	Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: Analysis from a phase 3 long-term extension study in children/young adults with Dravet syndrome.
11/2020	Fenfluramine HCl (Fintepla® ) provides long-term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open-label extension study.
1/2020	Slow Titration of Cannabidiol Add-On in Drug-Resistant Epilepsies Can Improve Safety With Maintained Efficacy in an Open-Label Study.
1/2020	Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial.
1/2019	Recent Advances in the Drug Treatment of Dravet Syndrome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rima Nabbout Research Topics

Disease

61	Epilepsy (Aura) 10/2022 - 04/2004
48	Seizures (Absence Seizure) 01/2022 - 10/2006
36	Tuberous Sclerosis (Bourneville's Disease) 01/2022 - 11/2012
24	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2022 - 07/2004
13	Brain Diseases (Brain Disorder) 01/2022 - 06/2008
9	Epileptic Syndromes 01/2021 - 03/2013
9	Infantile Spasms (West Syndrome) 01/2021 - 01/2009
8	Intellectual Disability (Idiocy) 01/2022 - 06/2013
7	Drug Resistant Epilepsy 03/2022 - 03/2008
7	Inborn Genetic Diseases (Disease, Hereditary) 01/2020 - 11/2014
6	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 07/2013
5	Status Epilepticus (Complex Partial Status Epilepticus) 01/2021 - 10/2010
5	Angiomyolipoma 01/2020 - 04/2016
5	Fever (Fevers) 01/2020 - 10/2010
3	Lennox Gastaut Syndrome 01/2022 - 11/2014
3	Channelopathies 01/2021 - 01/2013
3	Rare Diseases (Rare Disease) 01/2021 - 03/2013
3	Autism Spectrum Disorder 12/2020 - 06/2019
3	Idiopathic Generalized Epilepsy 10/2013 - 10/2006
3	Absence Epilepsy (Childhood Absence Epilepsy) 12/2009 - 10/2006
2	Cognitive Dysfunction 01/2022 - 01/2020
2	Spasm (Spasms) 01/2021 - 08/2003
2	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 01/2021 - 01/2021
2	Pyridoxine-dependent epilepsy 01/2021 - 07/2010
2	Diarrhea 01/2020 - 01/2017
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020 - 01/2016
2	Autistic Disorder (Autism) 01/2020 - 06/2019
2	Fatigue 01/2020 - 01/2017
2	Generalized Epilepsy with Febrile Seizures Plus 01/2019 - 07/2009
2	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2019 - 01/2017
2	Infections 04/2014 - 09/2012
2	Encephalitis (Encephalitis, Rasmussen) 08/2013 - 09/2012
2	Inflammation (Inflammations) 09/2012 - 01/2011
1	Neurodevelopmental Disorders 10/2022
1	Febrile Seizures (Febrile Seizure) 01/2022
1	Disease Progression 01/2021
1	Neoplasms (Cancer) 01/2021
1	Autoimmune Diseases of the Nervous System 01/2021
1	Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency 01/2021
1	Neurologic Manifestations (Neurological Manifestations) 01/2021
1	COVID-19 11/2020
1	Syncope (Fainting) 09/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Hamartoma 01/2020

Drug/Important Bio-Agent (IBA)

36	trans-sodium crocetinate (crocetin)IBA 01/2022 - 11/2012
23	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 04/2004
16	Pharmaceutical PreparationsIBA 01/2022 - 08/2003
11	Vigabatrin FDA Link 01/2021 - 01/2009
9	Everolimus FDA Link 12/2021 - 04/2016
9	CannabidiolIBA 10/2021 - 01/2017
8	stiripentolIBA 01/2020 - 07/2011
6	FenfluramineIBA 01/2022 - 01/2019
5	SteroidsIBA 01/2021 - 03/2008
4	Sodium Channels (Sodium Channel)IBA 01/2022 - 07/2009
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2019
3	Ion Channels (Ion Channel)IBA 01/2021 - 04/2004
3	TOR Serine-Threonine KinasesIBA 01/2021 - 10/2016
3	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 01/2019
3	Clobazam (HR 376)IBA 01/2020 - 01/2016
3	Immunoglobulin E (IgE)IBA 12/2009 - 10/2006
2	Aminobutyrates (Aminobutyric Acid)IBA 10/2022 - 03/2019
2	Pyridoxine (Pyridoxin)FDA LinkGeneric 01/2021 - 07/2010
2	MTOR InhibitorsIBA 01/2019 - 04/2016
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2019 - 01/2016
2	EnzymesIBA 01/2019 - 07/2010
2	N-Methylaspartate (NMDA)IBA 01/2019 - 09/2012
2	Biological ProductsIBA 01/2017 - 09/2012
2	SodiumIBA 01/2016 - 09/2015
2	Chloride Channels (Chloride Channel)IBA 03/2009 - 07/2007
2	Voltage-Gated Sodium ChannelsIBA 04/2006 - 07/2004
1	GABA-A Receptors (GABA(A) Receptor)IBA 10/2022
1	CytokinesIBA 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022
1	Red DND-99IBA 01/2022
1	Shaw Potassium ChannelsIBA 01/2021
1	VitaminsIBA 01/2021
1	Explosive Agents (Explosives)IBA 01/2021
1	Pyridoxal Phosphate (Pyridoxal 5 Phosphate)IBA 01/2021
1	Phosphates (Orthophosphate)IBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	beta Lactam AntibioticsIBA 04/2020
1	Carbapenems (Carbapenem Antibiotics)IBA 04/2020
1	Ceftazidime (Fortum)FDA LinkGeneric 04/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2020
1	beta-LactamsIBA 04/2020
1	Meropenem (Merrem)FDA LinkGeneric 04/2020
1	Cephalosporins (Cephalosporin Antibiotics)IBA 04/2020
1	CannabinoidsIBA 01/2020
1	Quinidine (Chinidin)FDA LinkGeneric 12/2019

Therapy/Procedure

26	Therapeutics 01/2022 - 01/2009
8	Ketogenic Diet 11/2020 - 04/2009
3	Transition to Adult Care 01/2020 - 01/2017
2	Off-Label Use 01/2018 - 03/2013
1	Genomic Medicine 03/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Treatment Delay 01/2021
1	Precision Medicine 12/2020
1	Ambulatory Care (Outpatient Care) 11/2020
1	Contraception (Birth Control) 01/2020